October 22, 2016 2:27 AM ET


Company Overview of Excaliard Pharmaceuticals, Inc.

Company Overview

Excaliard Pharmaceuticals, Inc., a biotechnology company, engages in the development and commercialization of drugs/therapeutics for the treatment of dermatological disorders. Its products include EXC 001, an antisense medicine for reducing fibrosis, the amelioration of skin scarring, and other fibrotic disorders/diseases. Excaliard Pharmaceuticals was founded in 2006 and is based in Carlsbad, California. As of November 30, 2011, Excaliard Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

2141 Palomar Airport Road

Suite 300

Carlsbad, CA 92011

United States

Founded in 2006





Key Executives for Excaliard Pharmaceuticals, Inc.

Chief Executive Officer, President, and Director
Age: 62
Chief Financial Officer
Age: 53
Chief Medical Officer
Head of Regulatory Affairs and Project Management
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Excaliard Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.